Comparative tumor analysis of CCL18 expression in GEPIA 2 (GEPIA 2) demonstrated significantly elevated expression levels in DLBCL relative to other malignant tumor types (Supplementary Figure 4A). This evidence concerns the gene CCL18 and neoplasm.